Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Critical Reviews in Immunology
|
January 17, 2008
Botulinum neurotoxin vaccines: past, present, and future
Leonard A Smith, Janice M Rusnak
Nature
|
September 14, 2012
Policy: Clarify the limits of climate models
David A Stainforth, Leonard A Smith
Protein Expression and Purification
|
November 22, 2005
Expression, purification, and characterization of Clostridium botulinum type B light chain
Janice Gilsdorf, Nizamettin Gul, Leonard A Smith
Nature Medicine
|
March 4, 2003
Prediction of epileptic seizures: are nonlinear methods relevant?
Patrick E McSharry, Leonard A Smith, Lionel Tarassenko
IEEE Transactions on Bio-Medical Engineering
|
May 29, 2003
Comparison of predictability of epileptic seizures by a linear and a nonlinear method
Patrick E McSharry, Leonard A Smith, Lionel Tarassenko
Biochemistry
|
October 29, 2003
Autocatalytically fragmented light chain of botulinum a neurotoxin is enzymatically active
S Ashraf Ahmed, Peter McPhie, Leonard A Smith
Plos One
|
September 30, 2010
Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form
Nizamettin Gul, Leonard A Smith, S Ashraf Ahmed
Basic & Clinical Pharmacology & Toxicology
|
November 18, 2004
Inhibition of the protease activity of the light chain of type A botulinum neurotoxin by aqueous extract from stinging nettle (Urtica dioica) leaf
Nizamettin Gul, S Ashraf Ahmed, Leonard A Smith
Journal of Pharmaceutical Sciences
|
February 20, 2009
Extreme sensitivity of botulinum neurotoxin domains towards mild agitation
Stephen I Toth, Leonard A Smith, S Ashraf Ahmed
Human Vaccines & Immunotherapeutics
|
August 3, 2012
Military vaccines in today's environment
Connie S Schmaljohn, Leonard A Smith, Arthur M Friedlander
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Critical Reviews in Immunology
|
January 17, 2008
Botulinum neurotoxin vaccines: past, present, and future
Leonard A Smith, Janice M Rusnak
Nature
|
September 14, 2012
Policy: Clarify the limits of climate models
David A Stainforth, Leonard A Smith
Protein Expression and Purification
|
November 22, 2005
Expression, purification, and characterization of Clostridium botulinum type B light chain
Janice Gilsdorf, Nizamettin Gul, Leonard A Smith
Nature Medicine
|
March 4, 2003
Prediction of epileptic seizures: are nonlinear methods relevant?
Patrick E McSharry, Leonard A Smith, Lionel Tarassenko
IEEE Transactions on Bio-Medical Engineering
|
May 29, 2003
Comparison of predictability of epileptic seizures by a linear and a nonlinear method
Patrick E McSharry, Leonard A Smith, Lionel Tarassenko
Biochemistry
|
October 29, 2003
Autocatalytically fragmented light chain of botulinum a neurotoxin is enzymatically active
S Ashraf Ahmed, Peter McPhie, Leonard A Smith
Plos One
|
September 30, 2010
Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form
Nizamettin Gul, Leonard A Smith, S Ashraf Ahmed
Basic & Clinical Pharmacology & Toxicology
|
November 18, 2004
Inhibition of the protease activity of the light chain of type A botulinum neurotoxin by aqueous extract from stinging nettle (Urtica dioica) leaf
Nizamettin Gul, S Ashraf Ahmed, Leonard A Smith
Journal of Pharmaceutical Sciences
|
February 20, 2009
Extreme sensitivity of botulinum neurotoxin domains towards mild agitation
Stephen I Toth, Leonard A Smith, S Ashraf Ahmed
Human Vaccines & Immunotherapeutics
|
August 3, 2012
Military vaccines in today's environment
Connie S Schmaljohn, Leonard A Smith, Arthur M Friedlander
Page
of 9